HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Requena Selected Research

Silvia Requena Research Topics

Disease

2Hepatitis C
01/2019 - 01/2017
2Chronic Hepatitis C
10/2018 - 01/2017
2HIV Infections (HIV Infection)
10/2018 - 05/2018
1Atherosclerosis
08/2022
1Inflammation (Inflammations)
08/2022
1Pneumonia (Pneumonitis)
01/2021
1COVID-19
01/2021
1Viremia
11/2019
1Fibrosis (Cirrhosis)
01/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2018
1Disease Progression
05/2018
1Infections
01/2017
1Hemolytic Anemia
01/2017

Drug/Important Bio-Agent (IBA)

3Antiviral Agents (Antivirals)IBA
01/2019 - 01/2017
1Messenger RNA (mRNA)IBA
08/2022
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2022
1oxidized low density lipoproteinIBA
08/2022
1Tissue Inhibitor of Metalloproteinase-2IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1CytokinesIBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1VaccinesIBA
05/2018
1InterferonsIBA
01/2017
1Raltegravir PotassiumFDA Link
01/2017
1Ribavirin (Virazole)FDA LinkGeneric
01/2017
1IntegrasesIBA
01/2017
1dolutegravirIBA
01/2017

Therapy/Procedure

3Therapeutics
11/2019 - 01/2017